Role of Efflux in Antibiotic Resistance of Achromobacter xylosoxidans and Achromobacter insuavis Isolates From Patients With Cystic Fibrosis
Achromobacter genus (including Achromobacter xylosoxidans, the most prevalent Achromobacter species in patients with cystic fibrosis) is poorly susceptible to most conventional antibiotics. Contribution of efflux by AxyABM, AxyXY-OprZ, and AxyEF-OprN and of target mutations were studied in clinical...
Main Authors: | Hussein Chalhoub, Stefanie Kampmeier, Barbara C. Kahl, Françoise Van Bambeke |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-03-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2022.762307/full |
Similar Items
-
Clinical impact of Achromobacter xylosoxidans colonization/infection in patients with cystic fibrosis
by: M.C. Firmida, et al.
Published: (2016-01-01) -
Osteomyelitis caused by Achromobacter xylosoxidans
by: Takashi Shinha, et al.
Published: (2015-01-01) -
Motility, Biofilm Formation and Antimicrobial Efflux of Sessile and Planktonic Cells of <i>Achromobacter xylosoxidans</i>
by: Signe M. Nielsen, et al.
Published: (2019-01-01) -
VEB-1 in Achromobacter xylosoxidans from Cystic Fibrosis Patient, France
by: Catherine Neuwirth, et al.
Published: (2006-11-01) -
Bacteremia due to Achromobacter xylosoxidans in neonates: clinical features and outcome
by: Ozden Turel, et al.